$SUND
Sundance Strategies, Inc. Stock $sund

$sund Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000149315224025765 Filed on July 01, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2024
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$166.8K	$159.6K	$531.4K
YoY Change	79.98%	1.23%	-22.11%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$166.8K	$159.6K	$44.00K
YoY Change	79.98%	1.22%	-93.55%
Operating Profit	-$166.8K		-$531.4K
YoY Change	79.98%		-22.11%
Interest Expense	-$101.6K	-$124.4K	$410.9K
YoY Change	-193.8%	100.32%	-207.02%
% of Operating Profit
Other Income/Expense, Net	-$101.6K		-$1.304M
YoY Change	-6.21%		-38.79%
Pretax Income	-$268.4K	-$932.8K	-$1.835M
YoY Change	33.54%	-41.25%	-34.74%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$268.4K	-$932.8K	-$1.835M
YoY Change	33.54%	-41.25%	-34.74%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01		-$0.04
Diluted Earnings Per Share	-$0.01	-$0.02	-$0.04
COMMON SHARES
Basic Shares Outstanding	42.44M shares	42.26M shares	41.69M shares
Diluted Shares Outstanding	43.04M shares		41.69M shares

Balance Sheet

Concept	2024 Q3	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$428.5K	$329.9K	$329.9K
YoY Change	131.62%	59874.55%	59874.55%
Cash & Equivalents	$428.5K	$329.9K	$329.9K
Short-Term Investments
Other Short-Term Assets	$17.56K	$9.080K	$9.080K
YoY Change	8.46%	9.4%	9.4%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$446.0K	$338.9K	$338.9K
YoY Change	121.71%	3729.77%	3729.83%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.00	$5.00	$0.00
YoY Change	-66.67%
TOTAL ASSETS
Total Short-Term Assets	$446.0K	$338.9K	$338.9K
Total Long-Term Assets	$1.00	$5.00	$0.00
Total Assets	$446.0K	$338.9K	$338.9K
YoY Change	121.71%	3729.83%	3729.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$447.7K	$447.9K	$447.9K
YoY Change	-3.32%	-40.53%	-40.53%
Accrued Expenses	$465.5K	$433.2K	$433.2K
YoY Change	-30.58%	-24.6%	-24.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$300.0K	$300.0K
YoY Change	-100.0%	0.0%	0.0%
Long-Term Debt Due	$300.0K	$50.00K	$50.00K
YoY Change	-65.75%	-94.29%	-94.29%
Total Short-Term Liabilities	$1.613M	$1.631M	$1.631M
YoY Change	-40.46%	-43.83%	-43.83%
LONG-TERM LIABILITIES
Long-Term Debt	$3.290M	$3.290M	$3.290M
YoY Change	37.89%	44.21%	44.21%
Other Long-Term Liabilities	$1.383M	$1.358M	$1.358M
YoY Change	43.27%	58.3%	58.3%
Total Long-Term Liabilities	$4.673M	$4.648M	$4.648M
YoY Change	39.44%	48.06%	48.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.613M	$1.631M	$1.631M
Total Long-Term Liabilities	$4.673M	$4.648M	$4.648M
Total Liabilities	$6.286M	$6.279M	$6.279M
YoY Change	3.71%	3.91%	3.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.60M	-$36.90M
YoY Change	5.62%	5.23%
Common Stock	$43.06K	$42.26K
YoY Change	3.5%	2.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.840M	-$5.940M	-$5.940M
YoY Change
Total Liabilities & Shareholders Equity	$446.0K	$338.9K	$338.9K
YoY Change	121.71%	3729.77%	3729.83%

Cashflow Statement

Concept	2024 Q3	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$268.4K	-$932.8K	-$1.835M
YoY Change	33.54%	-41.25%	-34.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$331.8K	-$226.4K	-$666.6K
YoY Change	268.33%	173.08%	45.01%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$850.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	575.0K	0.000	$996.0K
YoY Change	113.75%	-100.0%	417.91%
NET CHANGE
Cash From Operating Activities	-331.8K	-226.4K	-$666.6K
Cash From Investing Activities
Cash From Financing Activities	575.0K	0.000	$996.0K
Net Change In Cash	243.2K	-226.4K	$329.3K
YoY Change	35.93%	8606.92%	-223.15%
FREE CASH FLOW
Cash From Operating Activities	-$331.8K	-$226.4K	-$666.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001171838
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-50547
CY2024	dei	Entity Registrant Name EntityRegistrantName	SUNDANCE STRATEGIES, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0515333
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	4626 North 300 West
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite No. 365
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Provo
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84604
CY2024	dei	City Area Code CityAreaCode	(801)
CY2024	dei	Local Phone Number LocalPhoneNumber	717-3935
CY2024	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2024	dei	Trading Symbol TradingSymbol	SUND
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42438441	shares
CY2023Q3	dei	Entity Public Float EntityPublicFloat	8985742	usd
CY2024	dei	Auditor Firm AuditorFirmId	3627
CY2024	dei	Auditor Name AuditorName	Sadler, Gibb & Associates, LLC
CY2024	dei	Auditor Location AuditorLocation	Draper, UT
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	329860	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	553	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	9075	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8295	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	338935	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	8848	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	338935	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	8848	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	447862	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	753050	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	433201	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	574558	usd
CY2024Q1	SUND	Stock Repurchase Payable Current StockRepurchasePayableCurrent	400000	usd
CY2023Q1	SUND	Stock Repurchase Payable Current StockRepurchasePayableCurrent	400000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1631063	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2903608	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	1357739	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	857685	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4647797	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3139148	usd
CY2024Q1	us-gaap	Liabilities Liabilities	6278860	usd
CY2023Q1	us-gaap	Liabilities Liabilities	6042756	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42258441	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42258441	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41408441	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41408441	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	42259	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	41409	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30914682	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28986558	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36896866	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35061875	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-5939925	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6033908	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	338935	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8848	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	682283	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1047729	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1745808	usd
CY2024	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	290000	usd
CY2024	us-gaap	Interest Expense InterestExpense	410856	usd
CY2023	us-gaap	Interest Expense InterestExpense	329890	usd
CY2024	us-gaap	Financing Interest Expense FinancingInterestExpense	135000	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	54000	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1303585	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2129698	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1834991	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2811981	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-1834991	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811981	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41693714	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41693714	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41408441	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41408441	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-5026867	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	126130	usd
CY2023	SUND	Warrants Issued In Connection To Extinguishment Of Debt WarrantsIssuedInConnectionToExtinguishmentOfDebt	1678810	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811981	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6033908	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6033908	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	850000	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	114697	usd
CY2024	SUND	Warrants Issued In Connection To Extinguishment Of Debt WarrantsIssuedInConnectionToExtinguishmentOfDebt	964277	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-1834991	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-5939925	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-5939925	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-1834991	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811981	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1047729	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1745808	usd
CY2024	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	290000	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	67890	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	22487	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	780	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	128	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-15188	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	412023	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	358697	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	172078	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-666643	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-459713	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	850000	usd
CY2024	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	180950	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	192300	usd
CY2024	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	35000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	995950	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	192300	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	329307	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-267413	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	553	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	267966	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	329860	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	553	usd
CY2024	SUND	Issued Warrants As Debt Issuance Costs IssuedWarrantsAsDebtIssuanceCosts	114697	usd
CY2023	SUND	Issued Warrants As Debt Issuance Costs IssuedWarrantsAsDebtIssuanceCosts	126130	usd
CY2022Q1	SUND	Proceeds From Issuance Of Upon Contingent Milestones ProceedsFromIssuanceOfUponContingentMilestones	400000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_z6qiA7yKGUxb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zgufrlFocas9">Estimates</span>, </i>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14043573	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9403644	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	329860	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	553	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	79779	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2021Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	404087	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	124225	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	124225	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1500000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	9460611	shares
CY2022Q1	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingWeightedAverageExercisePrice	0.54
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	2153403	shares
CY2023	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Granted Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityGrantedWeightedAverageExercisePrice	1.05
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	11614014	shares
CY2023Q1	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingWeightedAverageExercisePrice	0.87
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	4639929	shares
CY2024	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Granted Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityGrantedWeightedAverageExercisePrice	0.51
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	14043573	shares
CY2024Q1	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingWeightedAverageExercisePrice	0.75
CY2024	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable	16253943	shares
CY2024Q1	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityExercisableWeightedAverageExercisePrice	0.75
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1106000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	14043573	shares
CY2024Q1	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	14043573	shares
CY2024	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	10517081	usd
CY2024	SUND	Liquidity And Capital Requirements Disclosure Textblock LiquidityAndCapitalRequirementsDisclosureTextblock	<p id="xdx_804_ecustom--LiquidityAndCapitalRequirementsDisclosureTextblock_zaIln21ZIpLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(9) <span id="xdx_828_z9FFHlhQim22">LIQUIDITY REQUIREMENTS AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the Company’s inception on January 31, 2013, its operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. As of March 31, 2024, the Company had $<span id="xdx_908_eus-gaap--Cash_iI_pp0p0_c20240331_zSco4gkt0r3h">329,890</span> of cash assets, compared to $<span id="xdx_90C_eus-gaap--Cash_iI_pp0p0_c20230331_z0Zbl0lTX0w1">533</span> as of March 31, 2023. As of March 31, 2024, the Company had access to draw an additional $<span id="xdx_902_ecustom--AdditionalBorrowingCapacityFromRelatedPartyNotesPayable_iI_pp0p0_c20240331_zDaNhSPBEdZ8">4,265,942</span> on the notes payable, related party (see Note 8) and $<span id="xdx_900_ecustom--AdditionalBorrowingCapacityOnConvertibleDebenture_iI_pp0p0_c20240331_zg9yCEKatQUh" title="Additional borrowing capacity from convertible debenture">3,000,000</span> on the Convertible Debenture Agreement (see Note 8). For the year ended March 31, 2024, the Company’s average monthly operating expenses were approximately $<span id="xdx_900_eus-gaap--OperatingExpenses_pp0p0_c20230401__20240331_z9ncr28eaJw7" title="Operating expenses">44,000</span>, which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and legal and accounting expenses. In addition to the monthly operating expenses, the Company continues to pursue other debt and equity financing opportunities, and as a result, financing expenses of $<span id="xdx_902_eus-gaap--FinancingInterestExpense_pp0p0_c20230401__20240331_zr7ZAJboHl91" title="Financing interest expense">135,000</span> and $<span id="xdx_907_eus-gaap--FinancingInterestExpense_pp0p0_c20220401__20230331_zgB5J2ei1lTi" title="Financing interest expense">54,000</span> were incurred during the years ended March 31, 2024, and 2023, respectively. As management continues to explore additional financing alternatives, beginning April 1, 2024 the Company is expected to spend up to an additional $<span id="xdx_90E_ecustom--AdditionalFinancingAlternatives_pp0p0_c20230401__20240331_zG0bwSlrtTKc">300,000</span> on these efforts. Outstanding Accounts Payable as of March 31, 2024 totaled $<span id="xdx_90A_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20240331_zFYdZ1Si6Cd" title="Accounts payable">447,862</span>. Management has concluded that its existing capital resources and availability under its existing convertible debentures and debt agreements with related parties will be sufficient to fund its operating working capital requirements for the 12 months from the issuance of the financial statements. Related parties have given assurance that their continued support, by way of either extensions of due dates, or increases in lines-of-credit, can be relied on. As mentioned above, the Company also continues to evaluate other debt and equity financing opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Cash	329890	usd
CY2023Q1	us-gaap	Cash Cash	533	usd
CY2024Q1	SUND	Additional Borrowing Capacity From Related Party Notes Payable AdditionalBorrowingCapacityFromRelatedPartyNotesPayable	4265942	usd
CY2024Q1	SUND	Additional Borrowing Capacity On Convertible Debenture AdditionalBorrowingCapacityOnConvertibleDebenture	3000000	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	44000	usd
CY2024	us-gaap	Financing Interest Expense FinancingInterestExpense	135000	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	54000	usd
CY2024	SUND	Additional Financing Alternatives AdditionalFinancingAlternatives	300000	usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	447862	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-385348	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-590516	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-67408	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-109962	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	258483	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	463012	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	194273	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	223229	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	14237	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7620722	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7387464	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	479708	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	479708	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8100430	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7867172	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1	pure
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	30822643	usd
CY2024	SUND	Operating Loss Carryforwards Expiration Date Description OperatingLossCarryforwardsExpirationDateDescription	expire in 2025
CY2024	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	greater than 50 percent
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd

Files In Submission

Name	View Source	Status
0001493152-24-025765-index-headers.html	Edgar Link	pending
0001493152-24-025765-index.html	Edgar Link	pending
0001493152-24-025765.txt	Edgar Link	pending
0001493152-24-025765-xbrl.zip	Edgar Link	pending
ex10-47.htm	Edgar Link	pending
ex10-47_001.jpg	Edgar Link	pending
ex10-48.htm	Edgar Link	pending
ex10-48_001.jpg	Edgar Link	pending
ex10-49.htm	Edgar Link	pending
ex10-49_001.jpg	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sund-20240331.xsd	Edgar Link	pending
sund-20240331_cal.xml	Edgar Link	unprocessable
sund-20240331_def.xml	Edgar Link	unprocessable
sund-20240331_lab.xml	Edgar Link	unprocessable
sund-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SUND
Sundance Strategies, Inc. Stock $sund

2024 Q3 Form 10-K Financial Statement

#000149315224025765 Filed on July 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SUND Sundance Strategies, Inc. Stock $sund

2024 Q3 Form 10-K Financial Statement

#000149315224025765 Filed on July 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SUND
Sundance Strategies, Inc. Stock $sund